Literature DB >> 4811882

The normal alveolar-arterial oxygen-tension gradient in man.

E A Harris, A M Kenyon, H D Nisbet, E R Seelye, R M Whitlock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4811882     DOI： 10.1042/cs0460089

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN： 0301-0538


× No keyword cloud information.
  6 in total

Review 1.  Differential diagnosis of hepatopulmonary syndrome (HPS): Portopulmonary hypertension (PPH) and hereditary hemorrhagic telangiectasia (HHT).

Authors:  Inna Krynytska; Mariya Marushchak; Anna Mikolenko; Anzhela Bob; Iryna Smachylo; Ludmyla Radetska; Olga Sopel
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

2.  Effects of exercise on gas exchange in patients recovering from acute severe asthma.

Authors:  G E Packe; W Freeman; R M Cayton
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

Review 3.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

4.  An analysis of the physiological strain of submaximal exercise in patients with chronic obstructive bronchitis.

Authors:  S G Spiro; H L Hahn; R H Edwards; N B Pride
Journal:  Thorax       Date:  1975-08       Impact factor: 9.139

5.  Oxygen and 99mTc-MAA shunt estimations in patients with pulmonary arteriovenous malformations: effects of changes in posture and lung volume.

Authors:  J Ueki; J M Hughes; A M Peters; G J Bellingan; M A Mohammed; J Dutton; W Ussov; D Knight; D Glass
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

6.  Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates.

Authors:  Michael B Fallon; Michael J Krowka; Robert S Brown; James F Trotter; Steven Zacks; Kari E Roberts; Vijay H Shah; Neil Kaplowitz; Lisa Forman; Keith Wille; Steven M Kawut
Journal:  Gastroenterology       Date:  2008-06-20       Impact factor: 22.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.